Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Authors / Sangeeta Tanna

Sangeeta Tanna

Sangeeta Tanna holds a PhD in pharmaceutics in the development of an artificial pancreas. Her expertise and research interests lie in the bioanalysis and drug delivery fields. This has led to the development of micro-analytical methodologies for the determination of therapeutic drugs from dried blood spots (DBS) based on LC-MS and LC-MS/MS studies for a range of clinical applications. This research was awarded the Royal Society of Chemistry Analytical Methods Prize in 2010. Applications of this work to patient care include improved medication for babies and people with cardiovascular diseases.

  • Contributions
Fields & Applications Mass Spectrometry

Spot On

April 15, 2013

Dried Blood Spot (DBS) sampling is being adopted in drug development, paediatric healthcare, and, more recently, patient compliance. We describe our positive experience with the platform, as well as the many advantages – and ongoing concerns – of this simple, stable, and versatile technology.

1 min read

Spot On
Fields & Applications Mass Spectrometry

Dried Blood Spot 101

April 15, 2013

1 min read

Dried Blood Spot 101
Fields & Applications Omics

Principal Drivers for DBS Research

April 15, 2013

It is now recognised that regarding a child as a scaled down adult to calculate a medicine dose may not be appropriate.

1 min read

Principal Drivers for DBS Research
Fields & Applications Pharma and Biopharma

Confronting Concerns

April 16, 2013

With many potential benefits, it is easy to understand the drive to develop systems and methods acceptable to the regulatory authorities but several difficulties have arisen.

1 min read

Confronting Concerns

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.